Drug Development and Toxicology Essay Example | Topics and Well Written Essays - 1000 words

Drug Development and Toxicology - Essay faceThe Food and Drug Administration (FDA) reports that most of the medicines reported to it do not come with sufficient information. The FDA says that medicate developing companies need to submit information on the compounds that are used to manufacture the medicine, uses of the drug and its cause among other important data. It reports that if companies submitted this kind of information, the drug approval process would be much quicker than the catamenia 8 years that are required. Consequently, it would increase the number of drugs that are clinically approved to enter the mart without any restrictions (Friedhoff, 2009). In the end, this will help save a lot of money as substantially as patients who die in during the approval period. One common reason for the discontinueed approvals is that drug development companies fail to indicate the optimal dosage that a patient should use so as to minimize the listed drug effects as well as any d angers associated with taking the drug. When undergoing the approval process, such a drug will be disqualified from the clinics conducting the trials have no way of knowing the appropriate dosage. FDA also mention that the populations that are sampled during drug development are very contrasting from the population that is meant to use the drug (Zanders, 2011). When clinical trials are being conducted and such an error is noted, the drug is disqualified as having been developed for a different population from the one that its safety tests were conducted on (Friedhoff, 2009).